Analysis persona
account_balanceDC Insider
Seasoned Washington political operative. Pragmatic, non-ideological, focused on power, procedure, and outcomes.
Analyses by DC Insider
S 323
Bipartisan, committee-reported coordination bill with low topline risk but two flashpoints (FAST‑41 expansion and a no-new-regulation clause) that...
S 4530
S.4530 let the Capitol Police Board set a retirement-age cap between 57 and 62; it cleared the Senate by unanimous consent on May 14, 2026, passed...
HR 8873
H.R. 8873 is a narrow, bipartisan anti-fraud bill that cleared House Ways & Means 41–0 on May 21, 2026 and was reported to the House on May 29. It...
HR 3490
H.R. 3490 cleared the House on June 3, 2025 by voice under suspension after a 42–0 committee vote, then passed the Senate by unanimous consent on May...
HR 1493
H.R. 1493 cleared House Energy & Commerce 43–0 on May 21, 2026, with bipartisan cosponsors and a live Senate companion (S.2898) in HELP—positioning...
HR 1703
Bipartisan Medicare wheelchair upgrade bill cleared House Energy & Commerce 45–0 on May 21, 2026, after a May 13 Health Subcommittee voice vote;...
HR 2001
Bipartisan dental-workforce reauthorization cleared House Energy & Commerce 44–0 on May 21, 2026, positioning H.R. 2001 for a likely House suspension...
HR 2145
Bipartisan recycling grant bill H.R. 2145 cleared House Energy & Commerce 48–0 and has industry coalition support; House GOP holds the gavel and the...
HR 2715
Bipartisan FDA-import safety bill H.R. 2715 cleared House Energy & Commerce 43–0 on May 21, 2026, signaling broad support. With Republicans holding...
HR 2821
H.R. 2821 (FDA Modernization Act 3.0) looks poised to clear the House with broad bipartisan support: the Energy & Commerce Committee reported it 44–0...
S 2666
Senate-originated, bipartisan, reported from Senate Commerce and positioned for quick floor action (hotline/UC) or as a low‑friction rider; House has...
HR 7892
House-origin, fraud-focused HEA amendment with clean markup and visible Senate HELP interest. Best path is as an LHHS appropriations rider or in a...
HR 1493
Clean, bipartisan TBI reauthorization that cleared House Energy & Commerce 43–0 on May 21, 2026, with a near‑identical Senate companion (S.2898) in...
HR 1703
Narrow Medicare DME fix with a clean, bipartisan House record and a Senate Finance companion parked at intro. Best path is as a low‑drama rider in a...
HR 2001
Small, bipartisan House reauthorization that E&C reported 44–0 on May 21, 2026; with Republicans running the White House, Senate (Thune) and a narrow...
HR 2145
House E&C reported H.R. 2145 by 48–0 on May 21, 2026; the Senate already passed the broader STEWARD Act (S. 351) embedding the same grant program on...
HR 2715
Bipartisan, low-cost FDA import‑safety tweak with real momentum: H.R. 2715 cleared House Energy & Commerce 43–0 on May 21, 2026; a Senate companion...
HR 2821
Senate has already passed the companion (S.355) by unanimous consent (Dec. 16, 2025). House Energy & Commerce reported H.R. 2821 by 44–0 on May 21,...
HR 3491
Bipartisan NIH authorization cleared House Energy & Commerce 46–0 on May 21, 2026; there’s a live Senate companion in HELP with bipartisan leads....
HR 3747
Bipartisan House E&C bill reauthorizing/expanding Project ECHO cleared full committee 48–0 on May 21, 2026; a bipartisan Senate companion (S.4036) is...
S 4530
S. 4530 is now law (signed May 29, 2026), expanding the U.S. Capitol Police Board’s discretion to set mandatory retirement anywhere from 57 to 62 by...
HR 7892
GOP controls the White House, House (220–215), and Senate (53–47). H.R. 7892 cleared committee 30–3 and was reported on May 26, 2026 (Union Calendar...
S 4631
Uncontroversial, bipartisan contractors’ whistleblower bill cleared the Senate by unanimous consent on May 21, 2026, and the message was sent to the...
HR 7891
Narrow, low‑cost oversight bill with unanimous (33‑0) committee support and fresh GPO report placement on the Union Calendar is primed for House...
HR 1493
Bipartisan TBI reauthorization cleared House Energy & Commerce 43–0 on May 21, 2026, positioning H.R. 1493 for near‑term House passage under a...
HR 1703
Niche, bipartisan Medicare fix with procedural tailwinds: after a 45–0 Energy & Commerce committee vote on May 21, 2026, H.R. 1703 is well‑positioned...
HR 2001
Narrow, bipartisan health reauthorization with a clean scope and a 44–0 committee vote is well-positioned to clear the House on suspension and the...
HR 2145
Bipartisan, low-salience EPA authorization cleared House Energy & Commerce 48–0 on May 21, 2026. With a razor-thin GOP House majority, the path is...
HR 2715
H.R. 2715 cleared House Energy & Commerce 43–0 on May 21, 2026, and with Republicans narrowly running the House and holding a 53‑seat Senate majority...
HR 2821
H.R. 2821 (FDA Modernization Act 3.0) cleared House Energy & Commerce by 44–0 on May 21, 2026, after a voice-vote advance from the Health...
HR 4754
House GOP Interior–Environment bill with extensive riders; Republicans control White House, House, and hold 53–seat Senate majority, but the 60‑vote...
HR 3944
H.R. 3944 cleared the Senate 87–9 and the House 218–206 and now sits in conference; with Republicans holding narrow House control and a 53–47 Senate,...
HR 4213
Bottom line: H.R. 4213 can likely clear the House on a partisan rule, but as written it cannot reach 60 in the Senate. Any path runs through a...
S 2844
S. 2844 (“Charlie Kirk Act”) would reinstate strict limits on U.S.‑funded foreign‑broadcast content being distributed inside the United States and...
S 2296
Pragmatic scoring of high‑salience FY26 NDAA provisions through a K Street/industry lens. Each item rates sector mapping, winners/losers, carve‑outs,...
S 2354
Bottom line: S. 2354 (CJS FY2026) is industry-aligned and earmark‑rich; with GOP control of the White House, Senate (53–47), and House, the bill’s...
HR 5680
Narrow shutdown carve‑out for public Navy shipyard pay intersects a major, well‑funded sector and powerful local delegations, but Appropriations...
HR 842
H.R. 842 sits in a sweet spot for diagnostics and patient groups, with GOP-led committees moving it and a friendly Senate Finance chair; expect House...
HR 2846
Narrow personnel-parity bill with negligible industry salience; reported out of House E&C on a 46–0 vote and sitting in a Republican-run Congress—so...
HR 3190
Low U.S. industry exposure; bipartisan momentum in House Foreign Affairs; GOP control in both chambers lowers friction; best vehicle is NDAA/SFOPS...
HR 3419
Low-controversy HRSA authorization with broad provider/tech backing, tiny topline ($42.05M/yr) and strong bipartisan committee signaling (E&C 48–0)...
HR 5371
Bottom line: H.R. 5371 is a short, status-quo CR plus health/VA/FDA extenders with a handful of narrow defense and program carve‑outs. It already...
SRES 412
Procedural, not policy: GOP-run Senate is using en bloc resolutions to accelerate confirmations. With Thune as majority leader, prior passage of a...
S 2882
S. 2882 is a short CR with a long list of anomalies plus a permanent ACA subsidy expansion. K Street largely favors the bill’s substance (defense,...
HRES 761
H.Res. 761 is a simple House resolution that expresses support for designating September 23, 2025, as “Bruce Springsteen Day.” Simple resolutions are...
HRES 766
H. Res. 766 is a nonbinding House simple resolution marking the Schomburg Center’s centennial; by design it carries no force of law, appropriations,...
HR 165
Targeted, low-cost land-status change for ~40 acres at Wounded Knee into restricted fee for the Oglala Sioux and Cheyenne River Sioux. Federal fiscal...
S 105
Low-cost, high-salience land‑status bill. S.105 would place 40 acres at Wounded Knee into restricted fee, non‑taxable status jointly for the Oglala...
S 1287
S.1287 (DELETE Act) would require FTC to build a centralized, hashed “one‑stop” deletion and do‑not‑collect mechanism for data brokers, backed by...
HR 5371
Institutionally, a short-term, largely "clean" CR through November 21 is mainstream procedure. But H.R. 5371 failed a 60‑vote test in the GOP‑run...
HR 5371
H.R. 5371 is a short-term continuing resolution through Nov. 21, 2025, with standard health and VA extenders and OTC monograph user-fee...
HR 3965
H.R. 3965 (PEARL Act) sits squarely in the mainstream-to-popular band: it formalizes an already-operational CBP support-canine effort, carries...
S 2296
Bottom line: The FY26 Senate NDAA (S.2296) sits in the ‘mainstream’ of U.S. defense policy on topline, China/Russia pacing threats, industrial base,...
HR 5107
Within the GOP-led governing coalition, H.R. 5107 (CLEAN DC Act) sits squarely in the “acceptable-to-popular” band; among Democrats and DC home‑rule...
HR 5214
GOP-led H.R. 5214 sits inside the Republican mainstream and at the edge of national acceptability: mandatory pretrial detention for violent/dangerous...
HR 5179
Nationally, H.R. 5179 sits outside the mainstream—perceived as a sharp rollback of D.C. home rule—yet it is acceptable within today’s House GOP and...
HR 5346
H.R. 5346 (Fair and Accountable IRS Reviews Act) sits in the “acceptable-to-mainstream” band of tax administration ideas: it codifies earlier,...
Persona Details
- Name
- DC Insider
- Description
- Seasoned Washington political operative. Pragmatic, non-ideological, focused on power, procedure, and outcomes.
- Status
- Active
- Created
- 13 Sep 2025